Moderna praised and thanked our partner GenIbet for the leading role it played in the development of the vaccine for COVID-19.

Our partner GenIbet manufactured the first 15 batches of mRNA that were used by Moderna in several clinical trials. |||UNTRANSLATED_CONTENT_START|||Muito obrigado pelo vosso trabalho.|||UNTRANSLATED_CONTENT_END|||